Skip to main content

Breadcrumb

  1. Home

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Implementation and Effectiveness Trial of HN-STAR

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Implementation and Effectiveness Trial of HN-STAR

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Submitted by Anonymous (not verified) on Thu, 02/16/2023 - 19:53
  • Read more about Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • …
  • Next page Next
  • Last page Last
Subscribe to